These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8345720)

  • 81. Minimal recruitment and activation of dendritic cells within renal cell carcinoma.
    Troy AJ; Summers KL; Davidson PJ; Atkinson CH; Hart DN
    Clin Cancer Res; 1998 Mar; 4(3):585-93. PubMed ID: 9533525
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens.
    Xu QB; Oberhuber G; Gruschwitz M; Wick G
    Clin Immunol Immunopathol; 1990 Sep; 56(3):344-59. PubMed ID: 2202532
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hypoexpression of major histocompatibility complex molecules on Legionella pneumophila phagosomes and phagolysosomes.
    Clemens DL; Horwitz MA
    Infect Immun; 1993 Jul; 61(7):2803-12. PubMed ID: 8514382
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Human leukocyte antigen expression in renal cell carcinoma lesions does not predict the response to interferon therapy.
    Mattijssen V; Van Moorselaar J; De Mulder PH; Schalkwijk L; Ruiter DJ
    J Immunother (1991); 1992 Jul; 12(1):64-9. PubMed ID: 1637784
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Phenotype frequency of human leukocyte antigens in Japanese patients with renal cell carcinoma who responded to interferon-alpha treatment.
    Onishi T; Ohishi Y; Iizuka N; Imagawa K
    Int J Urol; 1996 Nov; 3(6):435-40. PubMed ID: 9170569
    [TBL] [Abstract][Full Text] [Related]  

  • 86. HLA antigens in lyophilised corneal lenticules.
    Tabandeh H; Morris E; Rostron CK; Corbishley C
    Acta Ophthalmol Scand; 1998 Dec; 76(6):653-7. PubMed ID: 9881545
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Invariant chain expression in colon neoplasms.
    Jiang Z; Xu M; Savas L; LeClair P; Banner BF
    Virchows Arch; 1999 Jul; 435(1):32-6. PubMed ID: 10431843
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Brief communication: HLA antigen frequencies in renal cell carcinoma.
    Pollack MS; Livingston PO
    Hum Immunol; 1984 Nov; 11(3):151-3. PubMed ID: 6335146
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Monoclonal antibody analysis of major histocompatibility complex expression in human meningiomas.
    Becker I; Roggendorf W
    J Neuroimmunol; 1989 Dec; 25(2-3):161-7. PubMed ID: 2584394
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid.
    Admyre C; Grunewald J; Thyberg J; Gripenbäck S; Tornling G; Eklund A; Scheynius A; Gabrielsson S
    Eur Respir J; 2003 Oct; 22(4):578-83. PubMed ID: 14582906
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Both class I and class II HLA antigens are thyroid cancer susceptibility factors.
    Rigopoulou D; Martinez-Laso J; Martinez-Tello F; Alcaide JF; Benmamar D; Hawkins F; Arnaiz-Villena A
    Tissue Antigens; 1994 May; 43(5):281-5. PubMed ID: 7940496
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The relationship between human leukocyte antigens (HLA) and renal cell carcinoma.
    Yilmaz E; Çekmen A; Akkuş E; Önal B; Özalp AU; Solok V; Erdoğan E; Eren B
    Bosn J Basic Med Sci; 2010 Nov; 10(4):282-6. PubMed ID: 21108609
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Local immunosuppression determined by class II HLA antigen expression in patients with preclinical cervical carcinoma.
    Marinova-Mutafchieva L; Chakalova G
    Eur J Gynaecol Oncol; 1992; 13(6):494-7. PubMed ID: 1473530
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Major histocompatibility complex expression in brain of rats with graft-versus-host disease.
    Kajiwara K; Hirozane A; Fukumoto T; Orita T; Nishizaki T; Kamiryo T; Ito H
    J Neuroimmunol; 1991 Jun; 32(3):191-8. PubMed ID: 2033116
    [TBL] [Abstract][Full Text] [Related]  

  • 95. MAGED4-expression in renal cell carcinoma and identification of an HLA-A*25-restricted MHC class I ligand from solid tumor tissue.
    Krämer BF; Schoor O; Krüger T; Reichle C; Müller M; Weinschenk T; Hennenlotter J; Stenzl A; Rammensee HG; Stevanovic S
    Cancer Biol Ther; 2005 Sep; 4(9):943-8. PubMed ID: 16082191
    [TBL] [Abstract][Full Text] [Related]  

  • 96. MHC class I and II antigen expression and interferon alpha treatment of human midgut carcinoid tumors.
    Makridis C; Juhlin C; Akerström G; Oberg K; Rastad J
    World J Surg; 1994; 18(4):481-6; discussion 486-7. PubMed ID: 7725732
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Detection of empty HLA class II molecules on cord blood B cells.
    Garban F; Ericson M; Roucard C; Rabian-Herzog C; Teisserenc H; Sauvanet E; Charron D; Mooney N
    Blood; 1996 May; 87(9):3970-6. PubMed ID: 8611729
    [TBL] [Abstract][Full Text] [Related]  

  • 98. In situ demonstration of immunological heterogeneity in vascular endothelial cells of renal cell carcinoma.
    Kinjo T; Takashi M; Miyake K; Nagura H
    J Surg Oncol; 1990 Feb; 43(2):73-8. PubMed ID: 1689434
    [TBL] [Abstract][Full Text] [Related]  

  • 99. MHC expression of African green monkeys of Barbados is limited in heterogeneity.
    Lekutis C; Letvin NL
    J Med Primatol; 1995 Feb; 24(2):81-6. PubMed ID: 8613977
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Differential expression of interleukin-6, intracellular adhesion molecule 1, and major histocompatibility complex class II molecules in renal carcinoma cells stimulated with S fimbriae of uropathogenic Escherichia coli.
    Kreft B; Bohnet S; Carstensen O; Hacker J; Marre R
    Infect Immun; 1993 Jul; 61(7):3060-3. PubMed ID: 8099898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.